The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
UNITEPANC: Using organoids to predict efficacy of adjuvant treatment to improve outcome in resectable pancreatic cancer—Prospective, multicenter, proof-of-concept trial of the AIO Pancreatic Cancer Group.
 
Thomas Ettrich
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Takeda
Research Funding - Baxalta/Shire; Lilly (Inst)
Travel, Accommodations, Expenses - Ipsen; Lilly
 
Thomas Seufferlein
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Falk Foundation; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Cantargia AB; Mirati Therapeutics; Olympus Medical Systems; Pierre Fabre; Scandion Oncology; SERVIER
Research Funding - Lilly/ImClone (Inst)
Travel, Accommodations, Expenses - Takeda
 
Johannes Betge
No Relationships to Disclose
 
Jens Siveke
Leadership - Pharma15
Stock and Other Ownership Interests - Pharma15
Consulting or Advisory Role - AstraZeneca; AstraZeneca (Inst); Bayer; Bristol-Myers Squibb; Falk Foundation; Immunocore; MCI Deutschland; MSD; MSD; Novartis; Roche
Research Funding - Abalos GmbH (Inst); Bristol-Myers Squibb (Inst); Eisbach Bio (Inst); Roche (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Maximilian Reichert
No Relationships to Disclose
 
Uwe Pelzer
No Relationships to Disclose
 
Anke Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Aurikamed; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen-Cilag; Merck Serono; MSD; Pierre Fabre; Roche; Servier
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; MSD; Pierre Fabre; Roche
 
Waldemar Uhl
No Relationships to Disclose
 
Jessica Lindenmayer
No Relationships to Disclose
 
Lukas Perkhofer
Consulting or Advisory Role - AstraZeneca; SERVIER
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Alexander Kleger
No Relationships to Disclose